These findings suggest that a deeper understanding of CEACAM1 could reveal its importance in preventing hepatic insulin resistance associated with MASLD development and progression and could be a potential area of investigation for therapeutics targeting MASLD. The gene discussed is CEACAM1; the disease is Insulin resistance.